Role of vitamin D supplementation and vitamin D receptor in drug‐resistant epilepsy: A double‐blind placebo‐controlled trial conducted in India
Epilepsia · 2025-10 · 66 (10) · 3716-3729
DOI: 10.1111/epi.18492 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Epilepsia, online erschienen am 14.06.2025. Verfasst von Soumya S Pattnaik und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Hauptthemen laut MEDLINE: Receptors, Calcitriol, Vitamin D, Drug Resistant Epilepsy, Dietary Supplements. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: All-India Institute of Medical Sciences.
Abstract (Originalsprache)
Objective
Vitamin D has demonstrated potential anticonvulsant effects in experimental and pilot clinical studies; the results of these remain inconclusive. This study aims to investigate the efficacy and safety of adjunctive Vitamin D supplementation in reducing seizure frequency, modulating vitamin D receptor (VDR) activity, and altering the putative biomarkers of epileptogenesis in persons with drug‐resistant epilepsy (DRE).
Methods
This double‐blind, placebo‐controlled, parallel‐group, adjunctive trial recruited patients from a tertiary care hospital in India. Adult persons with DRE and serum Vitamin D levels
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
- Bennett University, Greater Noida, Uttar Pradesh, India.
- Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
- Department of Endocrinology, Metabolism and Diabetes, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
- University College Sedaya International (UCSI) University, Kuala Lumpur, Malaysia.
- Department of Biostatistics, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
ORCID-Profile: Sudhir C Sarangi, Jyotirmoy Banerjee
Förderung
- All-India Institute of Medical Sciences
Zitieren
APA
Pattnaik, S. S., Sarangi, S. C., Dash, Y., Singh, A., Goswami, R., Singh, S., Khan, M. A., Banerjee, J., Datta, S. K., & Tripathi, M. (2025). Role of vitamin D supplementation and vitamin D receptor in drug‐resistant epilepsy: A double‐blind placebo‐controlled trial conducted in India. Epilepsia, 66(10), 3716-3729. https://doi.org/10.1111/epi.18492
Vancouver
Pattnaik SS, Sarangi SC, Dash Y, Singh A, Goswami R, Singh S, et al. Role of vitamin D supplementation and vitamin D receptor in drug‐resistant epilepsy: A double‐blind placebo‐controlled trial conducted in India. Epilepsia. 2025;66(10):3716-3729. doi:10.1111/epi.18492
BibTeX
@article{Pattnaik2025,
author = {Pattnaik, Soumya S and Sarangi, Sudhir C and Dash, Yajnaseni and Singh, Archana and Goswami, Ravinder and Singh, Surender and Khan, Maroof A and Banerjee, Jyotirmoy and Datta, Sudip K and Tripathi, Manjari},
title = {Role of vitamin D supplementation and vitamin D receptor in drug‐resistant epilepsy: A double‐blind placebo‐controlled trial conducted in India},
journal = {Epilepsia},
year = {2025},
volume = {66},
number = {10},
pages = {3716--3729},
doi = {10.1111/epi.18492}
}
EUVIMED